Shares of Valneva SE (NASDAQ:VALN – Get Free Report) gapped down before the market opened on Tuesday after Guggenheim lowered their price target on the stock from $17.00 to $15.00. The stock had ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
Valneva’s 2024 Universal Registration Document – available in its entirety in French – includes the Company’s 2024 Annual Financial Report, the Company's Annual Management Report, the Board of ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...
Analysts have recently evaluated Valneva and provided 12-month price targets. The average target is $17.5, accompanied by a ...
Saint-Herblain (France), March 26, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) ("Valneva" or the "Company"), a specialty vaccine company, today announces that it has filed a prospectus ...
VALNEVA Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 ...
Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback